Antiretroviral Therapy News

 
 
  • CROI Darunavir Linked to Heightened Heart Disease Risk The early protease inhibitors are known to increase risk for heart attack, stroke, and sudden cardiac death. Now, data from the D:A:D study raise concerns about next-generation drugs.
  • New, Better-Tolerated Antiretrovirals Emerging for HIV Smaller pills, simplified regimens, and a novel integrase inhibitor hold promise for better-tolerated HIV treatment.
  • CROI 'Keeping the Foot on the Gas' of HIV Research at CROI 2017 Researchers will gather to discuss cure, prevention, and reaching vulnerable populations amid questions about the future of HIV funding and a scientific boycott.
  • Immediate ART for HIV Protects Against Severe Bacterial Infections Initiating, rather than deferring, antiretroviral therapy (ART) reduces the risk of severe bacterial infections in HIV-positive individuals with high CD4 counts, researchers say.
  • Role Reversal: Type 2 MIs in HIV as Common as Type 1 MIs "Traditional approaches such as instituting a statin are not going to have the same impact," suggests what's billed as the first study to tease out MI types in patients with HIV.
  • Quiz: Top Gastroenterology News Stories of 2016 PPIs, colonoscopy screening, and inflammatory bowel disease were among 2016's most popular topics in gastroenterology. Take the quiz to find out how well you remember the news most read by gastroenterologists.
  • GSK's Two-Drug HIV Therapy Shines in Two Big Studies GlaxoSmithKline's already fast-growing HIV drug business has received an important boost after two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS.
  • Top Cancer Doc: I Have HIV -- Stigma Can Be Devastating The name Eric Winer is practically synonymous with breast cancer research and treatment. He told his dramatic life story at this year's San Antonio Breast Cancer Symposium.
  • More Than 18 Million on HIV Treatment, a Million More Than 2015 More than 18 million people now have access to life-saving AIDS treatment, 1.2 million more than at the end of last year, the United Nations said on Monday.
  • Prenatal Combination ART Lowers HIV Risk, Ups Adverse Event Risk Combination antiretroviral therapy during pregnancy decreases the risk for HIV transmission to the neonate over zidovudine alone, but increases the risk for maternal and neonate adverse events.
  • Buyers Clubs for Cheaper Drugs Help Fight Hepatitis and HIV Frustrated by the high price of antiviral drugs, thousands of patients from London to Moscow to Sydney are turning to a new wave of online "buyers clubs" to get cheap generic medicines to cure hepatitis C and protect against HIV infection.
  • ANAC Nurses Tackle Tough Topics That Keep People in HIV Care The challenge of retaining HIV-infected patients in care, PrEP, hepatitis C coinfection, and transgender issues will all be addressed at the Association of Nurses in AIDS Care (ANAC) meeting.
  • Apps and Social Media Can Reach High-Risk HIV Populations Apps and social media can be used to deliver messages about HIV testing and medication adherence to thousands of people at high risk for HIV, experts report, and all at no cost.
  • HIV Glasgow Need to 'Step Up the Pace' to Reach Global 2020 UNAIDS Goals Treatment as prevention works, but reports show that access to therapy varies. Individual countries are closing in on the UNAIDS 90-90-90 targets, but collective success is lagging, experts say.
  • HIVR4P Latest ASPIRE Vaginal Ring Data Speak to Women's Experiences The effect of intimate-partner violence and sexual pleasure on adherence to the vaginal ring, which puts women in control of HIV prevention, is addressed in two new analyses of ASPIRE data.
  • Evidence Supports Once-Daily Pill for HIV-Infected Teens A small study of treatment-naïve adolescents with HIV infection helped pave the way for approval in the U.S. and elsewhere of the once-daily Genvoya tablet for HIV-infected adults and children age 12 and older, researchers say.
  • Fauci: Follow the Science to End the HIV/AIDS Epidemic Major scientific advances over 35 years have already led to the best way to treat the disease. And new science is turning up clues that could eventually lead to a cure, he said.
  • IDWeek Digs Deep Into Zika All aspects of the Zika virus will be addressed during the interdisciplinary IDWeek meeting, but lesser-known outbreaks, HIV, and climate change will also be discussed.
  • HIV: Hepatitis Coinfection May Increase Lymphoma Risk European multicohort study showed an increased risk for non-Hodgkins lymphoma among patients with HIV and chronic hepatitis B or hepatitis C coinfection.
  • HIV Summit Antiretroviral Clubs Support Patients With HIV HIV-positive communities formed in South Africa provide support systems, information sharing, and encourage adherence to daily medication, and leaders say the groups are working wonders.
  • HIV Summit New HIV PrEP Options Emerging, but Gold Standard Remains The current priority is to increase the uptake of once-daily oral pre-exposure prophylaxis, because it will likely be about 5 years before long-lasting injectable PrEP drugs make it to market.